Modulation of Inflammation in Cardiac Function after Myocardial Infarction

Behrooz G Sharifi*; Prediman K Shah

**Behrooz G Sharifi* and Prediman K Shah**

Volume6-Issue6
Dates: Received: 2025-06-03 | Accepted: 2025-06-13 | Published: 2025-06-16
Pages: 661-665

Abstract

FullText HTML FullText PDF DOI: 10.37871/jbres2120

Certificate of Publication

Copyright

How to cite this article

Sharifi BG, Shah PK. Modulation of Infl ammation in Cardiac Function after Myocardial Infarction. J Biomed Res Environ Sci. 2025 Jun 16; 6(6): 661-665. doi: 10.37871/jbres2120, Article ID: JBRES2120, Available at: https://www.jelsciences. com/articles/jbres2120.pdf

Subject area(s)

Pathology

Cardiovascular Diseases

Clinical Cardiology

References

Eapen ZJ, Tang WH, Felker GM, Hernandez AF, Mahaffey KW, Lincoff AM, Roe MT. Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):594-600. doi: 10.1161/CIRCOUTCOMES.112.966150. PMID: 22811505.
Nahrendorf M, Swirski FK. Monocyte and macrophage heterogeneity in the heart. Circ Res. 2013 Jun 7;112(12):1624-33. doi: 10.1161/CIRCRESAHA.113.300890. PMID: 23743228; PMCID: PMC3753681.
Ginhoux F, Schultze JL, Murray PJ, Ochando J, Biswas SK. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol. 2016 Jan;17(1):34-40. doi: 10.1038/ni.3324. PMID: 26681460.
Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W, Fukuda K, Sano M. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013 Sep;62:24-35. doi: 10.1016/j.yjmcc.2013.04.023. Epub 2013 May 2. PMID: 23644221.
Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014 May;11(5):255-65. doi: 10.1038/nrcardio.2014.28. Epub 2014 Mar 25. PMID: 24663091; PMCID: PMC4407144.
Hulsmans M, Sam F, Nahrendorf M. Monocyte and macrophage contributions to cardiac remodeling. J Mol Cell Cardiol. 2016 Apr;93:149-55. doi: 10.1016/j.yjmcc.2015.11.015. Epub 2015 Nov 21. PMID: 26593722; PMCID: PMC4846552.
Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001 Jan 16;134(2):136-51. doi: 10.7326/0003-4819-134-2-200101160-00015. PMID: 11177318.
Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschöpe C, Van Bilsen M, Zannad F, McMurray J, Shah AM. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 Feb;11(2):119-29. doi: 10.1093/eurjhf/hfn043. PMID: 19168509; PMCID: PMC2639409.
Dick SA, Epelman S. Chronic Heart Failure and Inflammation: What Do We Really Know? Circ Res. 2016 Jun 24;119(1):159-76. doi: 10.1161/CIRCRESAHA.116.308030. PMID: 27340274.
Dick SA, Epelman S. Chronic Heart Failure and Inflammation: What Do We Really Know? Circ Res. 2016 Jun 24;119(1):159-76. doi: 10.1161/CIRCRESAHA.116.308030. PMID: 27340274.
Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev. 2013 Oct 18;2013(10):CD004471. doi: 10.1002/14651858.CD004471.pub3. PMID: 24136037; PMCID: PMC8094275.
Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE; VISTA-16 Investigators. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2014 Jan 15;311(3):252-62. doi: 10.1001/jama.2013.282836. PMID: 24247616.
Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017 Mar 14;38(11):774-784. doi: 10.1093/eurheartj/ehw224. PMID: 27354052.
O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jan 29;61(4):485-510. doi: 10.1016/j.jacc.2012.11.018. Epub 2012 Dec 17. Erratum in: J Am Coll Cardiol. 2013 Sep 10;62(11):1039. PMID: 23256913.
Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011 Jul 25;11(8):519-31. doi: 10.1038/nri3024. PMID: 21785456.
Ma Y, Yabluchanskiy A, Lindsey ML. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair. 2013 Jun 3;6(1):11. doi: 10.1186/1755-1536-6-11. PMID: 23731794; PMCID: PMC3681584.
Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016 Jun 24;119(1):91-112. doi: 10.1161/CIRCRESAHA.116.303577. PMID: 27340270; PMCID: PMC4922528.
Nahrendorf M. Myeloid cell contributions to cardiovascular health and disease. Nat Med. 2018 Jun;24(6):711-720. doi: 10.1038/s41591-018-0064-0. Epub 2018 Jun 4. PMID: 29867229; PMCID: PMC7301893.
Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012 Apr 6;336(6077):86-90. doi: 10.1126/science.1219179. Epub 2012 Mar 22. PMID: 22442384.
Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume DA, Perlman H, Malissen B, Zelzer E, Jung S. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013 Jan 24;38(1):79-91. doi: 10.1016/j.immuni.2012.12.001. Epub 2012 Dec 27. Erratum in: Immunity. 2013 May 23;38(5):1073-9. PMID: 23273845; PMCID: PMC3908543.
Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, Greter M, Mortha A, Boyer SW, Forsberg EC, Tanaka M, van Rooijen N, García-Sastre A, Stanley ER, Ginhoux F, Frenette PS, Merad M. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013 Apr 18;38(4):792-804. doi: 10.1016/j.immuni.2013.04.004. PMID: 23601688; PMCID: PMC3853406.
Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010 Feb 5;327(5966):656-61. doi: 10.1126/science.1178331. Erratum in: Science. 2010 Dec 3;330(6009):1319. PMID: 20133564; PMCID: PMC2887389.
Bekkering S, van den Munckhof I, Nielen T, Lamfers E, Dinarello C, Rutten J, de Graaf J, Joosten LA, Netea MG, Gomes ME, Riksen NP. Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis. 2016 Nov;254:228-236. doi: 10.1016/j.atherosclerosis.2016.10.019. Epub 2016 Oct 12. PMID: 27764724.
Chakraborty S, Singh A, Wang L, Wang X, Sanborn MA, Ye Z, Maienschein-Cline M, Mukhopadhyay A, Ganesh BB, Malik AB, Rehman J. Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis. J Exp Med. 2023 Nov 6;220(11):e20221388. doi: 10.1084/jem.20221388. Epub 2023 Aug 24. PMID: 37615937; PMCID: PMC10450795.
Ghosh M, Rana S. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics. Int Immunopharmacol. 2023 May;118:110081. doi: 10.1016/j.intimp.2023.110081. Epub 2023 Mar 28. Erratum in: Int Immunopharmacol. 2023 Dec;125(Pt A):111089. doi: 10.1016/j.intimp.2023.111089. PMID: 36989901.
Toldo S, Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol. 2018 Apr;15(4):203-214. doi: 10.1038/nrcardio.2017.161. Epub 2017 Nov 16. PMID: 29143812.
Liu Y, Xu J, Wu M, Kang L, Xu B. The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction. J Cell Physiol. 2020 Dec;235(12):8996-9004. doi: 10.1002/jcp.29732. Epub 2020 Apr 30. PMID: 32352172.
Christia P, Frangogiannis NG. Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest. 2013 Sep;43(9):986-95. doi: 10.1111/eci.12118. Epub 2013 Jun 17. PMID: 23772948; PMCID: PMC3745791.